0000950170-23-045417.txt : 20230830
0000950170-23-045417.hdr.sgml : 20230830
20230830160603
ACCESSION NUMBER: 0000950170-23-045417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230829
FILED AS OF DATE: 20230830
DATE AS OF CHANGE: 20230830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAWES KAREN A
CENTRAL INDEX KEY: 0001261506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 231225301
MAIL ADDRESS:
STREET 1: 579 BELLEVUE AVE
CITY: NEWPORT
STATE: RI
ZIP: 02840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
ownership.xml
4
X0508
4
2023-08-29
0000730272
REPLIGEN CORP
RGEN
0001261506
DAWES KAREN A
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
true
false
false
false
false
Common Stock
2023-08-29
4
M
false
7392
18.12
A
84591
D
Common Stock
2023-08-29
4
S
false
850
171.38
D
83741
D
Stock Option (Right to Buy)
18.12
2023-08-29
4
M
false
7392
0.00
A
2024-05-15
Common Stock
7392
0
D
$171.38 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.37 to $171.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is fully vested and exercisable.
/s/ Kimberly Brown (Attorney in Fact)
2023-08-30